The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
High-fructose corn syrup enhances intestinal tumor growth in mice
Open accessAbstract
A sweetener's not-so-sweet effects: Obesity increases an individual's risk of developing many types of cancer, including colorectal cancer. One of the factors driving the rise in obesity rates is thought to be the use of high-fructose corn syrup (HFCS) as a sweetener in soft drinks. Goncalves et al. found that ingestion of HFCS promotes the growth of intestinal cancer even in the absence of obesity in mouse tumor models. An enzyme in tumors (ketohexokinase) converts fructose to fructose-1-phosphate, which alters tumor cell metabolism and leads to enhanced cell growth. Whether a similar process occurs in humans remains to be seen. Science , this issue p. 1345
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent animal study showed that high fructose corn syrup intake could induce intestinal tumourigenesis in mice by expediting glycolysis and de novo lipogenesis. The mice treated with the syrup had a substantially increased tumour size and tumour grade, independent of obesity and metabolic syndrome.124”
From Dietary sugar consumption and health: umbrella review (2023) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Nextflow enables reproducible computational workflows
Di Tommaso, P., Chatzou, M., Floden, E. W., Barja, P. P., Palumbo, E., & Notredame, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3820 · Cited by 4,001
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. C. (2008) · Nature · doi:10.1038/nature07602 · Cited by 2,232
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123
Intake of sugar-sweetened beverages and weight gain: a systematic review
Malik, V. S., Schulze, M. B., & Hu, F. B. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.2.274 · Cited by 2,100
Flagged first, then by citations
1 of the 52 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Targeting cancer metabolism in the era of precision oncology
Stine, Z. E., Schug, Z. T., Salvino, J. M., & Dang, C. V. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00339-6 · Cited by 1,189
Global patterns and trends in colorectal cancer incidence in young adults
Siegel, R. L., Torre, L. A., Soerjomataram, I., Hayes, R. B., Bray, F., Weber, T. K., & Jemal, A. (2019) · Gut · doi:10.1136/gutjnl-2019-319511 · Cited by 979
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2021) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 818
“…bodies (Xia et al., 2017; Hopkins et al., 2018), choline (Romano et al., 2017), arginine (PoilletPerez et al., 2018), glutamine (Ishak Gabra et al., 2020), fructose (Goncalves et al., 2019; Zhao et al., 2020), or cysteine (Badgley et al., 2020) mediates the progression of multiple types of cancer.”
BackgroundMetabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 675
Early-onset colorectal cancer: initial clues and current views
Hofseth, L. J., Hébert, J. R., Chanda, A., Chen, H., Love, B. L., Peña, M. M. O., Murphy, E. A., Sajish, M., Sheth, A., Buckhaults, P., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0253-4 · Cited by 448
Dietary modifications for enhanced cancer therapy
Kanarek, N., Petrova, B., & Sabatini, D. M. (2020) · Nature · doi:10.1038/s41586-020-2124-0 · Cited by 418
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 463
“185 Recently, glucose was reported to act as a signaling molecule, directly binding to and activating NSUN2, thereby activating NSUN2-TREX2 signaling.”
BackgroundDietary sugar consumption and health: umbrella review
Huang, Y., Chen, Z., Chen, B., Li, J., Yuan, X., Li, J., Wang, W., Dai, T., Chen, H., Wang, Y., et al. (2023) · BMJ · doi:10.1136/bmj-2022-071609 · Cited by 348
“124 Considering the different mechanisms of site specific cancers, further prospective studies that explore the definite associations between sugar consumption and cancer risk for diverse cancer types and ethnic groups are warranted.”
BackgroundSelf-citationZhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 356
Self-citationFinley, L. W. S. (2023) · Cell · doi:10.1016/j.cell.2023.01.038 · Cited by 343
Excessive intake of sugar: An accomplice of inflammation
Ma, X., Nan, F., Liang, H., Shu, P., Fan, X., Song, X., Hou, Y., & Zhang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988481 · Cited by 361
“Recently, it was demonstrated that excessive consumption of HFCS is associated with colon cancer development (123).”
BackgroundAcetyl-CoA metabolism in cancer
Guertin, D. A., & Wellen, K. E. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00543-5 · Cited by 303
Metabolic reprogramming in cancer: Mechanisms and therapeutics
Nong, S., Han, X., Yu, X., Qian, Y., Wei, Y., Zhang, T., Tian, K., Shen, K., Yang, J., & Ma, X. (2023) · MedComm · doi:10.1002/mco2.218 · Cited by 313
KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis
Xie, B., Zhang, M., Li, J., Cui, J., Zhang, P., Liu, F., Wu, Y., Deng, W., Ma, J., Li, X., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314128121 · Cited by 300
“It is reported that HFCS administration can be used to create a high - LA TME in vivo (30).”
BackgroundDietary fructose improves intestinal cell survival and nutrient absorption
Taylor, S. R., Ramsamooj, S., Liang, R. J., Katti, A., Pozovskiy, R., Vasan, N., Hwang, S.-K., Nahiyaan, N., Francoeur, N. J., Schatoff, E. M., et al. (2021) · Nature · doi:10.1038/s41586-021-03827-2 · Cited by 288
Self-citationZhang, D., Jin, W., Wu, R., Jia, L., Park, S.-A., Tu, E., Zanvit, P., Xu, J., Liu, O., Cain, A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.001 · Cited by 282
The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
Xavier, J. B., Young, V. B., Skufca, J. D., Ginty, F., Testerman, T. L., Pearson, A. T., Macklin, P., Mitchell, A., Shmulevich, I., Xie, L., et al. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.01.004 · Cited by 272
“Western diets havemany nutrients that can increase intestinal tumors [38].”
BackgroundColorectal Cancer in the Young: Epidemiology, Prevention, Management
Siegel, R. L., Jakubowski, C. D., Fedewa, S. A., Davis, A., & Azad, N. S. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_279901 · Cited by 252
Hur, J., Otegbeye, E., Joh, H.-K., Nimptsch, K., Ng, K., Ogino, S., Meyerhardt, J. A., Chan, A. T., Willett, W. C., Wu, K., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323450 · Cited by 229
Gluconeogenesis in cancer cells – Repurposing of a starvation-induced metabolic pathway?
Bluemel, G., Smolle, E., Olschewski, H., & Leithner, K. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.006 · Cited by 248
“When tumors where incubated in 13C-fructose in the absence of glucose ex vivo, a considerable conversion of fructose to glycolytic intermediates was found [107].”
BackgroundHigh-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity
Mana, M., Hussey, A. M., Tzouanas, C. N., Imada, S., Millan, Y. B., Bahceci, D. H., Saiz, D. R., Webb, A., Lewis, C. A., Carmeliet, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109212 · Cited by 209
“, 2016), high-fructose corn syrup (Goncalves et al., 2019), as well as low vitamin D (Peregrina et al.”
BackgroundDietary Approaches to Cancer Therapy
Tajan, M., & Vousden, K. H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.005 · Cited by 213
Metabolism and Colorectal Cancer
Sedlak, J. C., Yilmaz, Ö. H., & Roper, J. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-041113 · Cited by 208
Self-citationWestern diets and chronic diseases
Adolph, T. E., & Tilg, H. (2024) · Nature Medicine · doi:10.1038/s41591-024-03165-6 · Cited by 224
“Likewise, corn syrup and specifically dietary fructose enhances intestinal tumor growth in mutant mice 70,198 .”
“Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
Febbraio, M. A., & Karin, M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.004 · Cited by 185
“, 2020) and others (Goncalves et al., 2019) demonstrated that high fructose consumption can promote liver and colorectal tumorigenesis.”
BackgroundThe small intestine shields the liver from fructose-induced steatosis
Jang, C., Wada, S., Yang, S. H., Gosis, B. S., Zeng, X., Zhang, Z., Shen, Y., Lee, G., Arany, Z. P., & Rabinowitz, J. D. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0222-9 · Cited by 175
Self-citationDeveloping dietary interventions as therapy for cancer
Taylor, S. R., Falcone, J. N., Cantley, L. C., & Goncalves, M. D. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00485-y · Cited by 168
Self-citationFructose contributes to the Warburg effect for cancer growth
Nakagawa, T., Lanaspa, M. A., Millán, Í. S., Fini, M. A., Rivard, C. J., Sánchez‐Lozada, L. G., Andrés-Hernando, A., Tolan, D. R., & Johnson, R. J. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00222-9 · Cited by 151
“Importantly, knocking down fructokinase (ketohexokinase), the first enzyme involved in fructose metabolism, was found to suppress cancer growth in response to HFCS [67].”
BackgroundInfluentialA framework for examining how diet impacts tumour metabolism
Lien, E. C., & Vander Heiden, M. G. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0198-5 · Cited by 139
Dietary Fructose and Fructose-Induced Pathologies
Jung, S., Bae, H., Song, W., & Jang, C. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-025831 · Cited by 158
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota
Loke, Y. L., Chew, M. T., Ngeow, Y. F., Lim, W. W.-D., & Peh, S. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.603086 · Cited by 138
Joh, H.-K., Lee, D. H., Hur, J., Nimptsch, K., Chang, Y., Joung, H., Zhang, X., Rezende, L. F. M., Lee, J. E., Ng, K., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.03.028 · Cited by 122
Zhou, P., Chang, W.-Y., Gong, D.-A., Xia, J. L., Chen, W., Huang, L., Liu, R., Liu, Y., Chen, C., Wang, K., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.09.009 · Cited by 122
Oxidative Stress and Cancer Therapy: Controlling Cancer Cells Using Reactive Oxygen Species
Ju, S., Singh, M. K., Han, S., Ranbhise, J. S., Ha, J., Choe, W., Yoon, K., Yeo, S. G., Kim, S. S., & Kang, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212387 · Cited by 133
“HIF-2 α activation promotes pexophagy, which reduces peroxisome abundance and facilitates the accumulation of fat and sugar in ccRCC cells [202].”
Microenvironmental influences on T cell immunity in cancer and inflammation
Heintzman, D. R., Fisher, E. L., & Rathmell, J. C. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00833-2 · Cited by 119
Andrés-Hernando, A., Orlicky, D. J., Kuwabara, M., Ishimoto, T., Nakagawa, T., Johnson, R. J., & Lanaspa, M. A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.012 · Cited by 121
“Intake of these sugars is also of interest due to their relationship with other common medical illnesses, including cancer and dementia (Goncalves et al., 2019; Li et al., 2016; Stephan et al., 2010).”
BackgroundChen, H., Wang, J., Li, Z., Lam, C. W. K., Xiao, Y., Wu, Q., & Zhang, W. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16122192 · Cited by 112
Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take
Altea‐Manzano, P., Cuadros, A. M., Broadfield, L. A., & Fendt, S. (2020) · EMBO Reports · doi:10.15252/embr.202050635 · Cited by 123
“In a CRC model with APC loss in intestinal stem cells, fructose supplementation by water increased tumor initiation along-side increased body weight and impaired whole-body metabolism (Goncalves et al , 2019b).”
Li, M., He, X., Guo, W., Yu, H., Zhang, S., Wang, N., Liu, G., Sa, R., Shen, X., Jiang, Y., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0086-7 · Cited by 113
Disruption of the circadian clock drives Apc loss of heterozygosity to accelerate colorectal cancer
Chun, S. K., Fortin, B. M., Fellows, R. C., Habowski, A. N., Verlande, A., Song, W. A., Mahieu, A. L., Lefebvre, A. E. Y. T., Sterrenberg, J. N., Vélez, L. M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo2389 · Cited by 112
“In addition, HFD and high-fructose diet are known to accelerate CRC by regulating de novo lipogenesis ( 97 ).”
Dietary excess regulates absorption and surface of gut epithelium through intestinal PPARα
Stojanović, O., Altirriba, J., Rigo, D., Spiljar, M., Evrard, E., Roska, B., Fabbiano, S., Zamboni, N., Maechler, P., Rohner‐Jeanrenaud, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27133-7 · Cited by 106
“[1-2] [2-5] [5-10] [10-20] [20+] 0 10 20 30 40”
Colorectal Cancer in Younger Adults
Dharwadkar, P., Zaki, T. A., & Murphy, C. C. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.02.005 · Cited by 112
Self-citationKrause, N., & Wegner, A. (2020) · Cells · doi:10.3390/cells9122635 · Cited by 103
“Recently, it was observed that fructose, even at a moderate dose, induces fatty acid synthesis and can enhance tumorigenesis in mice [92].”
BackgroundHou, Y., Wei, W., Guan, X., Liu, Y., Bian, G., He, D., Fan, Q., Cai, X., Zhang, Y., Wang, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20673-4 · Cited by 101
Fructose Production and Metabolism in the Kidney
Nakagawa, T., Johnson, R. J., Andrés-Hernando, A., Roncal-Jiménez, C. A., Sánchez‐Lozada, L. G., Tolan, D. R., & Lanaspa, M. A. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019101015 · Cited by 99
Metabolomics, metabolic flux analysis and cancer pharmacology
Liang, L., Sun, F., Wang, H., & Hu, Z. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107827 · Cited by 99
Microbiota-driven mechanisms at different stages of cancer development
Ivleva, E., & Grivennikov, S. I. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100829 · Cited by 99
“[80] Goncalves MD , Lu C , Tutnauer J , Hartman TE , Hwang SK , Murphy CJ , et al.”
BackgroundThe Molecular Link from Diet to Cancer Cell Metabolism
Bose, S., Allen, A. E., & Locasale, J. W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.018 · Cited by 94
Szeri, F., Lundkvist, S., Donnelly, S., Engelke, U. F. H., Rhee, K. Y., Williams, C. J., Sundberg, J. P., Wevers, R. A., Tomlinson, R. E., Jansen, R. S., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008884 · Cited by 83
“Moreover, given its wide tissue distribution, we hypothesized ANKH has functions beyond regulation of extracellular PPi homeostasis, and applied global metabolite profiling [10] on medium of HEK293-ANKH cells to gain a comprehensive overview of metabolites extruded by cells in an ANKH-dependent manner.”
MethodSelf-citationHigh Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells
Jeong, S., Savino, A. M., Chirayil, R., Barin, E., Cheng, Y., Park, S., Schurer, A., Mullarky, E., Cantley, L. C., Kharas, M. G., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.005 · Cited by 78
“Fructose is predominantly metabolized through ketohexokinase (KHK), rather than hexokinase (HK), in the small intestine and liver, the canonical organs of fructose metabolism (Andres-Hernando et al., 2020; Diggle et al., 2009; Goncalves et al., 2019; Jang et al., 2018; Lanaspa et al., 2018), but it is unknown whether…”
BackgroundSelf-citationSugars and Gastrointestinal Health
Arnone, D., Chabot, C., Heba, A.-C., Kökten, T., Caron, B., Hansmannel, F., Dreumont, N., Ananthakrishnan, A. N., Quilliot, D., & Peyrin‐Biroulet, L. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.011 · Cited by 91
ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis
Adorno-Cruz, V., Hoffmann, A. D., Liu, X., Dashzeveg, N. K., Taftaf, R., Wray, B. D., Keri, R. A., & Liu, H. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.015 · Cited by 78
“Moreover, recent findings show a contribution of de novo fatty acid synthesis (in which ACLY is involved) in intestinal tumorigenesis of adenomatous polyposis coli (APC) mutant mice.(58) Our studies confirm a modulation of ACLY expression by CD49b signaling pathway and a role of ACLY in breast cancer self-renewal, sho…”
BackgroundMetabolic determinants of tumour initiation
Brunner, J. S., & Finley, L. W. S. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00773-5 · Cited by 78
Chang, V. C., Cotterchio, M., De, P., & Tinmouth, J. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01456-8 · Cited by 74
The Good, the Bad and the New about Uric Acid in Cancer
Allegrini, S., Garcia‐Gil, M., Pesi, R., Camici, M., & Tozzi, M. G. (2022) · Cancers · doi:10.3390/cancers14194959 · Cited by 76
“[58] have identified KHK as the “key accelerator of tumor growth”.”
BackgroundInfluentialHexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth
Yan, H., Wang, Z., Teng, D., Chen, X., Zhu, Z., Chen, H., Wang, W., Wei, Z., Wu, Z., Chai, Q., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.10.002 · Cited by 72
Self-citationMannose Treatment: A Promising Novel Strategy to Suppress Inflammation
Zhang, W., Cheng, H., Gui, Y., Zhan, Q., Li, S., Qiao, W., & Tong, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.756920 · Cited by 71
“For example, one study reported that glucose-fructose syrup (HFCS) enhances intestinal tumor growth in mice via activation of glycolysis and increased synthesis of fatty acids in tumor cells that support tumor growth (1); Another study found that high fructose intake is associated with increased hepatic fatty acid syn…”
BackgroundIntestinal plasticity and metabolism as regulators of organismal energy homeostasis
Stojanović, O., Miguel‐Aliaga, I., & Trajkovski, M. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00679-6 · Cited by 74
Dietary fructose-mediated adipocyte metabolism drives antitumor CD8+ T cell responses
Zhang, Y., Yu, X., Bao, R., Huang, H., Gu, C., Lv, Q.-M., Han, Q., Du, X., Zhao, X.-Y., Ye, Y., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.09.011 · Cited by 66
Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease
Johnson, R. J., Gómez‐Pinilla, F., Nagel, M. A., Nakagawa, T., Rodríguez‐Iturbe, B., Sánchez‐Lozada, L. G., Tolan, D. R., & Lanaspa, M. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.560865 · Cited by 70
Rathmell, J. C. (2021) · New England Journal of Medicine · doi:10.1056/nejmcibr2035081 · Cited by 64
Macronutrient Determinants of Obesity, Insulin Resistance and Metabolic Health
Wali, J. A., Solon‐Biet, S. M., Freire, T., & Brandon, A. E. (2021) · Biology · doi:10.3390/biology10040336 · Cited by 74
Liu, T., Lin, J., Chen, C., Nie, X., Dou, F., Chen, J., Wang, Z., & Gong, Z. (2020) · Cell Proliferation · doi:10.1111/cpr.12954 · Cited by 63
Lathigara, D., Kaushal, D., & Wilson, R. B. (2023) · Metabolites · doi:10.3390/metabo13050675 · Cited by 64
“Otto Warburg’s original theory that cancer developed as a result of dysfunctional mitochondria and increased cytoplasmic glycolysis is also supported by the cascade of oncogenic pathways involving sustained cytoplasmic-nuclear signalling initiated by diet, obesity and the metabolic syndrome [19,24].”
BackgroundInfluentialAmino acid variability, tradeoffs and optimality in human diet
Dai, Z., Zheng, W., & Locasale, J. W. (2022) · Nature Communications · doi:10.1038/s41467-022-34486-0 · Cited by 61
The fructose survival hypothesis for obesity
Johnson, R. J., Lanaspa, M. A., Sánchez‐Lozada, L. G., Tolan, D. R., Nakagawa, T., Ishimoto, T., Andrés-Hernando, A., Rodríguez‐Iturbe, B., & Stenvinkel, P. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0230 · Cited by 64
“The effect of fructose to decrease mitochondrial oxidative phosphorylation and stimulate glycolysis (Warburg effect) provides an explanation for why cancer cells prefer fructose as a growth media [111], and why cancer cell growth is stimulated by both fructose and uric acid [112,113].”
BackgroundInteractions between diet and gut microbiota in cancer
Nakatsu, G., Andreeva, N., MacDonald, M. H., & Garrett, W. S. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01736-4 · Cited by 58
“…on the findings discussed earlier in this Perspective regarding beneficial microbes modulating stem cell metabolism, one could speculate that lactobacilli in probiotics might liberate sugar compounds to crossfeed stem cells and tumour cells, thus negatively affecting therapeutic response 84,85,99 .”
Shen, Z., Li, Z., Liu, Y., Li, Y., Feng, X., Zhan, Y., Lin, M., Fang, C., Fang, Y., & Deng, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215617 · Cited by 53
Dietary fructose enhances tumour growth indirectly via interorgan lipid transfer
Fowle-Grider, R., Rowles, J. L., Shen, I., Wang, Y., Schwaiger-Haber, M., Dunham, A. J., Jayachandran, K., Inkman, M. J., Zahner, M. C., Naser, F. J., et al. (2024) · Nature · doi:10.1038/s41586-024-08258-3 · Cited by 55
Self-citationEpner, M., Yang, P., Wagner, R. W., & Cohen, L. G. (2022) · Cancers · doi:10.3390/cancers14246042 · Cited by 56
“Extensive research now supports the role for multiple mechanisms whereby sugar modifies cancer risk, independent of obesity, including inflammation, glucose/fructose metabolism, lipid metabolic pathways, and immune modulation (Figure 2) [17,76,77,92].”
BackgroundDietary Fructose Promotes Prostate Cancer Growth
Carreño, D. V., Corro, N. B., Cerda-Infante, J. F., Echeverría, C. E., Asencio-Barría, C. A., Torres-Estay, V. A., Mayorga-Weber, G. A., Rojas, P. A., Véliz, L. P., Cisternas, P., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-19-0456 · Cited by 51
“Stimulatory effect of fructose on tumor growth also was reported in certain subtypes of breast (11) and intestinal (12) cancers.”
BackgroundEarly-onset colorectal cancer as an emerging disease of metabolic dysregulation
Du, M., Drew, D. A., Goncalves, M. D., Cao, Y., & Chan, A. T. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01159-z · Cited by 51
Self-citationMicrobiome in cancer progression and therapy
Andreeva, N., Gabbasova, R. R., & Grivennikov, S. I. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.09.001 · Cited by 48
“Diets modulate cancer risk and some do so through the metabolic activity of microbiota [72–74] involved in the regulation of lipid or cholesterol metabolism [75,76] or fructose content [77,78].”
BackgroundNutritional Control of Intestinal Stem Cells in Homeostasis and Tumorigenesis
Calibasi‐Kocal, G., Mashinchian, O., Başbınar, Y., Ellidokuz, E., Cheng, C., & Yilmaz, Ö. H. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.11.003 · Cited by 47
USP19 exacerbates lipogenesis and colorectal carcinogenesis by stabilizing ME1
Zhu, Y., Gu, L., Lin, X., Zhou, X., Lu, B., Liu, C., Lei, C., Zhou, F., Zhao, Q., Prochownik, E. V., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110174 · Cited by 47
Nutrient transporters: connecting cancer metabolism to therapeutic opportunities
Nwosu, Z. C., Song, M. G., di Magliano, M. P., Lyssiotis, C. A., & Kim, S. E. (2023) · Oncogene · doi:10.1038/s41388-023-02593-x · Cited by 51
Hernandez, G. V., Smith, V. A., Melnyk, M., Burd, M. A., Sprayberry, K. A., Edwards, M. S., Peterson, D. G., Bennet, D. C., Fanter, R. K., Columbus, D. A., et al. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00344.2019 · Cited by 44
Yuan, C., Joh, H., Wang, Q.-L., Zhang, Y., Smith‐Warner, S. A., Wang, M., Song, M., Cao, Y., Zhang, X., Zoltick, E. S., et al. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac040 · Cited by 46
Mechanisms and Functions of Pexophagy in Mammalian Cells
Li, J., & Wang, W. (2021) · Cells · doi:10.3390/cells10051094 · Cited by 52
“High fructose consumption and metabolism contribute to the development of many pathologic conditions such as cancer [71].”
BackgroundVLM catecholaminergic neurons control tumor growth by regulating CD8 + T cells
Zhang, Z., Li, Y., Lv, X., Zhao, L., & Wang, X. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103505118 · Cited by 45
Food Intake and Colorectal Cancer
Kumar, A., Chinnathambi, S., Kumar, M., & Pandian, G. N. (2023) · Nutrition and Cancer · doi:10.1080/01635581.2023.2242103 · Cited by 46
Early-onset cancers: Biological bases and clinical implications
Mauri, G., Patelli, G., Bianchi, A. S., Abrignani, S., Bodega, B., Marsoni, S., Costanzo, V., Bachi, A., Siena, S., & Bardelli, A. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101737 · Cited by 51
“62 Coculturing models rather than in vivo mice models could be exploited to investigate the role of the immune system in EO cancers (Table 1).”
BackgroundDietary and metabolic effects on intestinal stem cells in health and disease
Shay, J. E. S., & Yilmaz, Ö. H. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00980-7 · Cited by 47
“This increase in intestinal tumorigenesis was due to tumour uptake of HFCS leading to augmented glycolysis and de novo lipogenesis through ketohexokinase 142 .”
InfluentialPeng, C., Yang, P., Zhang, D., Jin, C., Peng, W., Wang, T., Sun, Q., Chen, Z., Feng, Y., & Sun, Y. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.04.024 · Cited by 43
“Specifically, the fructose concentration was significantly increased in the colonic lumen (4.4 mmol/L at peak) in mice treated with high-fructose corn syrup 44 .”
BackgroundInfluentialFan, S., Wang, W., Che, W., Xu, Y., Jin, C., Dong, L., & Xia, Q. (2025) · Metabolites · doi:10.3390/metabo15030201 · Cited by 43
ATF4-dependent fructolysis fuels growth of glioblastoma multiforme
Chen, C., Zhang, Z., Liu, C., Wang, B., Liu, P., Fang, S., Yang, F., You, Y., & Li, X. (2022) · Nature Communications · doi:10.1038/s41467-022-33859-9 · Cited by 42
Cui, Y., Tian, J., Wang, Z., Guo, H., Zhang, H., Wang, Z., Liu, H., Song, W., Liu, L., Tian, R., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0464 · Cited by 41
“For instance, in lung and intestinal tumors, fructose can promote tumor growth by increasing fatty acids synthesis (8, 17).”
BackgroundCellular metabolic reprogramming controls sugar appetite in Drosophila
Carvalho-Santos, Z., Cardoso-Figueiredo, R., Elias, A. P., Tastekin, I., Baltazar, C., & Ribeiro, C. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0266-x · Cited by 40
Science-Driven Nutritional Interventions for the Prevention and Treatment of Cancer
Montégut, L., de Cabo, R., Zitvogel, L., & Kroemer, G. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0504 · Cited by 38
Tee, S. S., Kim, N., Cullen, Q., Eskandari, R., Mamakhanyan, A., Srouji, R. M., Chirayil, R., Jeong, S., Shakiba, M., Kastenhuber, E. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm7985 · Cited by 39
“Recent work in a genetically modified mouse model of intestinal tumor has shown avid metabolism of fructose via KHK (29).”
Liu, T., Jing, F., Huang, P., Geng, Z., Xu, J., Li, J., Chen, D., Zhu, Y., Wang, Z., Huang, W., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13089 · Cited by 38
Cancer metabolism and dietary interventions
Qian, L., Zhang, F., Yin, M., & Lei, Q. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0461 · Cited by 40
Zhou, W., Wu, C.-C., Limbu, S. M., Li, R., Chen, L., Qiao, F., Luo, Y., Zhang, M., Han, T., & Du, Z. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.737857 · Cited by 38
Kim, J.-H., Kim, Y., La, J., Park, W. H., Kim, H.-J., Park, S. H., Ku, K. B., Kang, B. H., Lim, J., Kwon, M. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113220 · Cited by 39
Self-citationStangis, M. M., Chen, Z., Min, J., Glass, S. E., Jackson, J. O., Radyk, M. D., Hoi, X. P., Brennen, W. N., Yu, M., Dinh, H. Q., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1550 · Cited by 37
Early life high fructose impairs microglial phagocytosis and neurodevelopment
Wang, Z., Lipshutz, A. B., de la Torre, C. M., Trzeciak, A. J., Liu, Z.-L., Miranda, I. C., Lazarov, T., Codo, A. C., Romero-Pichardo, J. E., Nair, A., et al. (2025) · Nature · doi:10.1038/s41586-025-09098-5 · Cited by 48
“The selected fructose dosage is 45% of the typical 100 mg per mouse dose delivered daily by oral gavage to adult mice, which was determined to be equivalent to 3% of total daily caloric intake and analogous to human consumption of less than 12 oz of sugar-sweetened drink 59 .”
GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase
Liang, R. J., Taylor, S. R., Nahiyaan, N., Song, J., Murphy, C. J., Dantas, E., Cheng, S., Hsu, T.-W., Ramsamooj, S., Grover, R., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00246-9 · Cited by 36
Self-citationArnone, D., Vallier, M., Hergalant, S., Chabot, C., Ndiaye, N. C., Moulin, D., Aignatoaei, A.-M., Alberto, J., Louis, H., Boulard, O., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.758518 · Cited by 43
“This observation aligns with increasing evidence that dietary sugars are involved in colorectal carcinogenesis, both in humans and animals (16, 37, 44).”
BackgroundBeites, T., Jansen, R. S., Wang, R., Jinich, A., Rhee, K. Y., Schnappinger, D., & Ehrt, S. (2021) · Nature Communications · doi:10.1038/s41467-021-26941-1 · Cited by 36
Self-citation
Metadata
- Authors
- Goncalves, M. D., Lu, C., Tutnauer, J., Hartman, T. E., Hwang, S.-K., Murphy, C. J., Pauli, C., Morris, R., Taylor, S., Bosch, K., Yang, S., Wang, Y., Van Riper, J., Lekaye, H. C., Roper, J., Kim, Y., Chen, Q., Gross, S. S., Rhee, K. Y., Cantley, L. C., & Yun, J.
- Affiliations
- Weill Cornell Medicine (US)
- University Hospital Zurich (CH)
- Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
- Tisch Cancer Institute (US)
- Baylor College of Medicine (US)
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Duke University (US)
- Chonnam National University (KR)
- Corresponding author
- Cantley, Lewis C.
- Yun, Jihye
- ORCID
- Venue
- Science
- Published
- 2019-03-22
- Volume
- 363
- Issue
- 6433
- Pages
- 1345-1349
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6487857
- OpenAlex
- W2922809418
- Cited by
- 374
- References
- 52
- Citations by year
- 2026: 32 · 2025: 36 · 2024: 44 · 2023: 66 · 2022: 56 · 2021: 70 · 2020: 55 · 2019: 15
- FWCI
- 39.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Institutes of Health (R01 NS093872, R35 CA197588, KL2 Scholar 2014 [Y8-H], CA230318)
- National Cancer Institute (1K22CA216036)
- National Institute of Child Health and Human Development (PO1 HD067244)
- Stand Up To Cancer Colorectal Cancer Dream Team Translational Research Grant (SU2C-AACR-DT22-17)
- Cancer Prevention and Research Institute of Texas (RR170039)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- high fructose corn syrup, colorectal cancer, fructose, dietary glucose, fructose-1-phosphate, glycolysis, fatty acid synthesis, carcinogenesis, sugar-sweetened beverages, obesity
- MeSH terms
- Animals, Diet, Intestinal Neoplasms, Mice, Mutant Strains, Adenomatous Polyposis Coli Protein, Tumor Burden, Mice, Neoplasm Grading, Carcinogenesis, High Fructose Corn Syrup
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
